SIMILASAN Toux irritative glob 15 g

7680513400448 CH-51340 20.01.1.
SIMILASAN Toux irritative glob 15 g
SIMILASAN Toux irritative glob 15 g
1 / 2
google

Details

Product number
5134001
CPT
-
Packaging group
15
Unit
g
Composition
drosera (HAB) D3 6.000 mg, drosera (HAB) D6 2.000 mg, drosera (HAB) D12 2.000 mg, calcii carbonas, xylitolum, ad globulos pro 1 g, corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Reizhusten, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/03/2013
Patient information leaflet
Français
12/03/2013
Patient information leaflet
Italien
12/03/2013

Detailed composition

Substance Quantity Type Category
(N/A)
6.0 MG Substance Wirkstoff (Principe actif)
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
51340
Drug name
Similasan Reizhusten, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
17/10/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei trockenem Husten mit Schmerzen hinter dem Brustbein; Reizhusten, Kitzelhusten mit Brechreiz; Hustenanfällen

Packaging details

Description (FR)
SIMILASAN Toux irritative glob 15 g
Description (DE)
SIMILASAN Reizhusten Glob 15 g
Market launch
17/10/1991
Narcotic (BTM)
No

Other packaging sizes